News

pharmaphorum6d
FDA widens label for BMS’ cancer drug Augtyro | pharmaphorum
Bristol-Myers Squibb gets FDA approval for Augtyro for NTRK gene fusion-positive solid tumours. Skip to main content Wednesday 25 June 2025 . BlueSky linkedin youtube rss. User account menu ...
Fusion superkine and focused ultrasound could enable targeted, noninvasive therapy for glioblastoma
Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have discovered a ...
AlphaGalileo6d
The Role of Fusion Genes in Cancer Development and Treatment
Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer ...
News Medical on MSN5d
Fusion genes found to be pivotal players in cancer development
Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer ...
AZoLifeSciences on MSN5d
Fusion Genes Emerge as Key Drivers in Cancer Development
Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer ...
Nature6d
CRISPR-Cas9 genome editing - Latest research and news - Nature
CRISPR-Cas9 genome editing articles from across Nature Portfolio. Atom; RSS Feed; Definition. CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner.